- Home
- WKSP vs NERV Comparison
WKSP vs NERV Comparison
Compare WKSP & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- NERV
- Stock Information
- Founded
- WKSP 2003
- NERV 2007
- Country
- WKSP United States
- NERV United States
- Employees
- WKSP N/A
- NERV N/A
- Industry
- WKSP Auto Parts:O.E.M.
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- NERV Health Care
- Exchange
- WKSP Nasdaq
- NERV Nasdaq
- Market Cap
- WKSP 14.6M
- NERV 12.6M
- IPO Year
- WKSP N/A
- NERV 2014
- Fundamental
- Price
- WKSP $3.03
- NERV $1.77
- Analyst Decision
- WKSP Strong Buy
- NERV Hold
- Analyst Count
- WKSP 3
- NERV 1
- Target Price
- WKSP $12.83
- NERV $5.00
- AVG Volume (30 Days)
- WKSP 177.5K
- NERV 12.2K
- Earning Date
- WKSP 08-12-2025
- NERV 08-05-2025
- Dividend Yield
- WKSP N/A
- NERV N/A
- EPS Growth
- WKSP N/A
- NERV N/A
- EPS
- WKSP N/A
- NERV 0.83
- Revenue
- WKSP $10,211,747.00
- NERV N/A
- Revenue This Year
- WKSP $159.92
- NERV N/A
- Revenue Next Year
- WKSP $68.25
- NERV N/A
- P/E Ratio
- WKSP N/A
- NERV $2.18
- Revenue Growth
- WKSP 407.96
- NERV N/A
- 52 Week Low
- WKSP $2.44
- NERV $1.15
- 52 Week High
- WKSP $12.00
- NERV $3.50
- Technical
- Relative Strength Index (RSI)
- WKSP 50.10
- NERV 57.10
- Support Level
- WKSP $2.80
- NERV $1.62
- Resistance Level
- WKSP $3.14
- NERV $1.83
- Average True Range (ATR)
- WKSP 0.28
- NERV 0.09
- MACD
- WKSP -0.01
- NERV -0.00
- Stochastic Oscillator
- WKSP 30.00
- NERV 64.29
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.